Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial.
- Published In:
- EClinicalMedicine, 72, 102624 (2024)
- Authors:
- Hansen, Morten S, Wölfel, Eva M, Jeromdesella, Shakespeare, Møller, Jens-Jakob K, Ejersted, Charlotte, Jørgensen, Niklas R, Eastell, Richard, Hansen, Stinus G, Frost, Morten
- Database ID:
- RPEP-08344
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08344APA
Hansen, Morten S; Wölfel, Eva M; Jeromdesella, Shakespeare; Møller, Jens-Jakob K; Ejersted, Charlotte; Jørgensen, Niklas R; Eastell, Richard; Hansen, Stinus G; Frost, Morten. (2024). Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial.. EClinicalMedicine, 72, 102624. https://doi.org/10.1016/j.eclinm.2024.102624
MLA
Hansen, Morten S, et al. "Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial.." EClinicalMedicine, 2024. https://doi.org/10.1016/j.eclinm.2024.102624
RethinkPeptides
RethinkPeptides Research Database. "Once-weekly semaglutide versus placebo in adults with increa..." RPEP-08344. Retrieved from https://rethinkpeptides.com/research/hansen-2024-onceweekly-semaglutide-versus-placebo
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.